Equels Thomas K - Insider Non-Derivative Transactions at AIM ImmunoTech Inc. (AIM) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 16, 2024, Equels Thomas K's relationship to AIM ImmunoTech Inc. (AIM) is Director,Officer (CEO & President), and currently has 1,493,042 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AIM insiders.

Data Source: SEC.
Equels Thomas K - Insider Non-Derivative Transactions of AIM Common Stock
Equels Thomas K - Insider Non-Derivative Transactions at AIM
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 17, 2024 P -- (Common Stock) 5000 0.3 1493042
Sep 14, 2024 P -- (Common Stock) 20000 0.31 1488042
Sep 12, 2024 Acquisition -- (Common Stock) 312500 0.32 1468042
Aug 13, 2024 Acquisition -- (Common Stock) 377358 0.27 1155542
May 7, 2024 P -- (Common Stock) 61729 0.41 778184
Mar 16, 2024 P -- (Common Stock) 75758 0.33 716455
Nov 28, 2023 P -- (Common Stock) 33861 0.44 640697
Sep 30, 2023 P -- (Common Stock) 22676 0.44 606836
Aug 26, 2023 P -- (Common Stock) 8222 0.67 584160
Aug 25, 2023 P -- (Common Stock) 14993 0.67 575938
Jul 18, 2023 P -- (Common Stock) 16950 0.59 560945
Jan 4, 2023 P -- (Common Stock) 161291 0.31 543995